In the present data, we found that Candida albicans (C. albicans) caused bladder epithelial cell morphology alteration, cell damage, and inflammatory responses, including cyclooxygenase-2 (COX-2) gene and protein expression as well as prostaglandin E 2 accumulation. In addition, the molecular pathway underlying C. albicans-induced urothelial COX-2 gene expression was examined. Among MAPK pathways, phosphorylation of ERK1/2, p38, and JNK each increased following C. albicans infection for 12 h. However, C. albicans-induced COX-2 protein expression was inhibited by specific inhibitors of ERK and p38 (U0126 and SB203580) but not by JNK inhibitor SP600125. Additional evidence came from the increased amount of phosphorylated RSK that is the mutual downstream molecule of ERK1/2 and p38. Furthermore, phosphorylation of RSK protein was reduced by the ERK and p38 inhibitor, suggesting that the urothelial COX-2 gene was induced majorly though the ERK/p38-RSK pathway by C. albicans infection. We also found transcription factor CREB-1 showed increased binding to the COX-2 gene promoter by chromatin immunoprecipitation assay. Next, we used receptor inhibitors including Toll-like receptor (TLR)-Myd88 inhibitor ST2825, Dectin-Syk inhibitor Syk inhibitor, and epidermal growth factor receptor (EGFR) inhibitor PD168393 to identify which one was the main target associated with C. albicans binding. The results revealed that it was EGFR, recognized by C. albicans, that mostly mediated the ERK/p38-RSK pathway activation to induce COX-2 gene expression, but this was not the case for TLRs and Dectin receptors. In summary, these results demonstrated the EGFR-ERK/p38-RSK-CREB-1 Wang et al.
Introduction
Nosocomial infection is often a troublesome problem worldwide. In the United States, Candida species are the fourth most frequently isolated pathogens in nosocomial bloodstream infections among 49 hospitals. 1 Nosocomial candidemia is associated with a higher mortality (61%) than that expected from the underlying disease alone (12%). 2 In addition to the bloodstream, Candida species also infect other tissue sites, particularly the urinary tract when urinary catheters are applied to intensive care unit (ICU) patients. 3 In France, the crude mortality of ICU candiduric patients reaches 31%. 4 In addition to ICU patients, candiduria is also more prevalent in patients who take broad spectrum antibiotics, have urinary tract abnormalities or diabetes mellitus, and have undergone abdominal surgeries or corticosteroid treatment. 3 In general, candiduria could be a marker for patients who might develop bad outcomes. It was reported that antifungal therapy does not reduce candiduria recurrence rates in hospitalized patients in a long-term follow-up study. 5 Therefore, more understanding of the interaction between the urothelium and Candida species might provide some therapeutic ideas for candiduria. More than 150 species of Candida have been found, but only 15 species cause infectious diseases in humans. 6 Based on the analysis data from 21 hospitals in Taiwan, Candida albicans (C. albicans) (72.3%) is the most common species in all yeast isolates, followed by C. tropicalis (12.3%) and C. glabrata (11.7%). 7 C. albicans is a benign mucosal fungal flora in most healthy people. Its yeast form grows benignly and is tolerated by the host immune system. 8 However, it may cause mucosal disease when local or systemic antifungal defense abilities decrease. 9 It was reported that the incidence of nosocomial candidemia increased 36-fold from 1981 to 2000 in Taiwan. 10 According to the epidemiological investigation, the extensive use of antifungal agents resulted in the alteration of Candida species that cause invasive infections. In addition, the incidence of species other than C. albicans also has increased gradually over the past two decades. 6 Mucosal epithelial cells are an important barrier for defending the invasion of C. albicans. It is known that yeast cells adhere to epithelia, rapidly switch to hyphal growth, and then penetrate the epithelial apical sites and the intercellular spaces between adjacent cells or invade the epithelial cells via induced endocytosis. 11 It is still a debate whether hyphae are necessary for virulence, but the yeast-to-hyphae transition is believed to be associated with increased virulence gene expression and virulence development. 12 In addition to being a physical defense barrier, mucosal epithelia also produce various proinflammatory mediators to recruit and activate immune cells, including neutrophils, dentritic cells, and T cells, for protection against C. albicans. 13 In oral epithelial cells, C.
albicans induces G-CSF, GM-CSF, interleukin (IL)-1α, and IL-6 expression, 14 while mutants without normal filament formation reduce the induction ability of cytokines. 15 C. albicans also induces inflammatory cyclooxygenase-2 (COX-2) expression in human cervical epithelial cells 16 and rat synovial fibroblasts. 17 COX-2 catalyzes the formation of prostaglandins, which play various biological roles, including immunological regulation, inflammation, and proliferation. 18 One of the prostaglandins, PGE 2 , has been reported to enhance the yeast-to-hypha transition of C. albicans, which contributes to the virulence mechanism for host. 19 Because candiduric infection is a troublesome issue in ICU patients and the mechanism underlying urinary bladder infection caused by C. albicans interaction is incompletely understood, in the present study we analyzed C. albicansinduced COX-2 expression in human urothelial cells and attempted to make clear the cellular signaling pathways involved. Elucidation of the associated potential molecules will provide a greater understanding of C. albicans pathogenesis impinged on the host urinary tract.
Material and methods

Reagents and antibodies
U0126, SB203580, and SP600125 were purchased from Tocris Bioscience (Bristol, UK). Syk inhibitor was from Millipore (Darmstadt, Germany), ST2825 was from ApExBio (Houston, TX, USA), and PD168393 was from Merk (Darmstadt, Germany). Antibodies against cyclooxygenase-2 (07-693) was purchased from Millipore Upstate (Billerica, MA, USA). Anti-EGFR antibodies (sc-03) was from Santa Cruz (Dallas, TX. USA). Antibodies against α-tubulin and β-actin were from GeneTex (Irvine, CA, USA). All phosphor-protein antibodies were purchased from Cell Signaling Technology (Danvers, MA, USA).
Cell culture, yeast culture, and co-culture Human bladder carcinoma TSGH8301 cells and C. albicans (Robin) Berkhout were obtained from the Bioresource Collection and Research Center (Hsinchu, Taiwan). TSGH8301 cells were maintained in Roswell Park Memorial Institute (RPMI) 1640 medium supplied with 10% fetal bovine serum (FBS), 1% penicillin, and 1% streptomycin and were incubated in a CO 2 incubator at 37
• C, with 5% CO 2 and 95% filtered air. C. albicans were grown and isolated in Potato Dextrose Agar (PDA) after thawing. To prepare yeasts for co-culture, they were picked from a single colony and grown in yeast malt medium. In the log growing stage of C. albicans, they were co-cultured with near confluent TSGH8301 cells in the six-well plate with multiplicity of infection (MOI) 0.5, 1, 2, or 4. The co-culture plates were incubated in a CO 2 incubator at 37
• C, with 5% CO 2 and 95% filtered air.
Lactate dehydrogenase (LDH) release assay
The LDH release assay kit (No. 10008882) was purchased from Cayman Chemical (Ann Arbor, MI, USA) and operated following the instructions. The reaction products were measured by an enzyme-linked immunosorbent assay (ELISA) reader at 490 nm.
Reverse transcription PCR
Reverse transcription (RT) was performed on 2 μg of total RNA by 5 μM random hexamer and RevertAid TM reverse transcriptase (Thermo Fisher Scientific, Waltham, MA, USA), then 1/16 volume of reaction mixture was used for polymerase chain reaction (PCR) with cyclooxygenase-2 specific primers (forward: 5 -TGCCACAATCTGGCTGCGGG-3 , reverse: 5 -TGGCATCTGGCCGAGGCTTT-3 ) and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) specific primers (forward: 5 -CAAGGTCATCCATGACAACTTTG-3 , reverse: 5 -GTCCACCACCCTGTTGCTGTAG-3 ). The PCR products (cyclooxygenase-2: 647 bp; GAPDH: 496 bp) were analyzed by 1% agarose gel.
Prostaglandin E 2 concentration assay
After co-incubation of TSGH8301 cells and C. albicans, the extracellular medium containing synthesized PGE 2 was determined by PGE 2 ELISA kit (Cayman Chemical, Ann Arbor, MI, USA) following the instructions. PGE 2 production was measured by an ELISA reader at 420 nm.
Western blotting
Analytical 10% sodium dodecyl sulfate (SDS)-polyacrylamide slab gel electrophoresis was performed. After co-culture, TSGH8301 protein extractions were prepared and 30 μg protein extracts of each sample were analyzed. For immune-blotting, proteins in the SDS-PAGE gels were transferred to a polyvinylidene difluoride membrane by a trans-blot apparatus. Antibodies against specific target proteins were used as the primary antibodies. Immunoblot analysis was carried out with anti-mouse, rabbit or goat immunoglobulin G (IgG) antibodies coupled to horseradish peroxidase. The enhanced chemiluminescence kit and VL Chemi-Smart 3000 were used for detection, and the quantity of each band was determined by the software of MultiGauge.
Chromatin immunoprecipitation (ChIP) assay
After co-incubation of TSGH8301 cells and C. albicans in six-well plates, cells were crosslinked with 1% formaldehyde at 37
• C for 10 min, washed twice with PBS, and scrapped cells into tubes, then centrifuged at 400× g for 4 min at 4
• C to collect cells. Added SDS Lysis Buffer (50 mM Tris-HCl (pH 8.1), 1% SDS, 10 mM EDTA, and protease inhibitor cocktail) to the cell pellets for 10 min on ice, and cells were sonicated to shear the size of DNA to 500-1000 bp. Sonicated extracts were diluted 10-fold with a ChIP Dilution Buffer (16.7 mM Tris-HCl (pH 8.1), 0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 167 mM NaCl, and protease inhibitor cocktail), then took a certain volume for input control. Diluted sonicated extracts were incubated with 75 μl of salmon sperm DNA-saturated 50% protein A-sepharose (Millipore, Darmstadt, Germany) at 4
• C for 30 min for pre-cleaning, then centrifuged at 100× g for 1 min at 4
• C to collect supernatants for immunoprecipita- The PCR products were also separated by 1% agarose-gel electrophoresis. For real-time PCR assay, GM SYBR qPCR kit (GMbiolab, Taichung, Taiwan) was used for DNA amplification.
Statistical analysis
Statistical differences were analyzed using ANOVA oneway analysis of variance analysis. The Student t-test was used for calculating P values. All statistics were calculated using SigmaPlot version 12.5 (Systat Software, San Jose, CA, USA).
Results
Induction of urothelial cell damage by C. albicans infection
Because it is well known that damage of the superficial epithelium is a characteristic feature of UTI Candidiasis, 20 we used an LDH release assay to investigate the toxicity caused by C. albicans to disrupt urinary bladder epithelial cells in vitro. After co-incubation of TSGH8301 cells with C. albicans (Fig. 1A) , cell morphology was found to change remarkably from a spindle-shaped and closely arranged phenotype into a more rounded and wrinkled appearance. In addition, the extent of TSGH8301 cell damage was presented with a time-and MOI-dependent man- ner (Fig. 1B) . At 24 h, the LDH release ratios reached as high as 6.71-and 7.41-fold compared to noninfected control under MOI = 2 and 4 conditions, respectively. However, at this time point we observed visually that most of the cells were dead and that the amount of attached cells was less than 30%. At 12 h of infection, the LDH release ratio lowered to 4.13-fold, and the number of viable cells was more than 50% by microscope observation.
Candida albicans infection induced COX-2 expression
Previous studies have shown that C. albicans can induce COX-2 expression in cervical epithelial cells, synovial fibroblasts, and oral epithelial cells and that expression correlated with inflammatory episode. 16, 17, 21 Here, we assessed whether C. albicans also could lead to a similar occurrence The results were derived from three independent assays and are presented as the means ± SE. * : P < .05, * * : P < .01, * * * : P < .001 compared to MOI = 0.
in urinary bladder cells. As shown in Figure 2 , after coculture of TSGH8301 cells with C. albicans, both RT-PCR and Western blot analyses showed a MOI-dependent induction of COX-2 mRNA ( Fig. 2A ) and COX-2 protein synthesis (Fig. 2B) , respectively. The COX-2 protein level increased to almost 2.5-fold at 12 h and further to fivefold at 18 h comparing MOI = 0 and 4. Furthermore, a small amount of C. albicans (such as MOI = 0.5) was able to drive COX-2 protein synthesis remarkably after 18 h. In addition, we found pro-inflammatory cytokine IL-8 and transcription factor c-Jun also were upregulated in response to stimulation of C. albicans (data not shown). To determine whether the enhanced COX-2 protein expression also acted to elevate prostaglandin formation, PGE 2 was measured. The results revealed significant PGE 2 increased in both time-and MOI-dependent behaviors, consistent with COX-2 measurements (Fig. 2C ). These findings indicated that the synthesized PGE 2 by Candida-infected TSGH8301 cells might contribute to further induction of the inflammatory environment and epithelial damage. Because COX-2 protein induction was not significant after infection for 6 h (data not shown), the conditions of 12-h infection accompanied by MOI = 2 and 4 would be adopted to investigate the signaling pathway in the following experiments.
ERK and p38 MAPK pathways were involved in C. albicans-induced COX-2 expression
Many studies have suggested that C. albicans will activate cell signaling via MAPKs, PI3K, or NF-κB pathways in host epithelial cells to produce an inflammatory response. 14, 22, 23 To investigate the plausible MAPK pathways involved in C. albicans-induced activation of COX-2 in TSGH8301 cells, various inhibitors of associated pathways were pretreated for 1 h before C. albicans co-culture, including an ERK1/2 inhibitor (U0126), a p38 inhibitor (SB203580), and a JNK inhibitor (SP600125). According to the data presented in Figure 3 by Western blot analysis using specific antibodies against each MAPK molecule, it was found that COX-2 expression was inhibited significantly by either U0126 or SB203580 application. In contrast, SP600125 had no effect on suppression of C. albicans-induced COX-2 production. The results were derived from three independent assays and presented as the means ± SE. * : P < .05, * * : P < .01, * * * : P < .001 compared to each individual DMSO only.
Moreover, the evidence was more pronounced by the upregulation of p90-RSK, which is the common downstream route of ERK and p38, confirming these two pathways played critical roles in C. albicans-induced COX-2 activation in TSGH8301 cells. However, as for the relevance of NF-κB, we found COX-2 expression was not inhibited by pretreatment with NF-κB inhibitor Ro-1069920 (data not shown), suggesting the NF-κB pathway was not associated with C. albicans-induced COX-2 activation in TSGH8301 cells.
Involvement of transcription factor CREB-1 binding to the COX-2 promoter for COX-2 gene activation
Since our data indicated that transcription of COX-2 was upregulated significantly in response to C. albicans coculture, we investigated further which transcription factor would contribute to the regulation of C. albicansstimulated COX-2 induction. So far, some binding sites have been reported to exist at the COX-2 promoter, such as NF-κB, Sp1, AP-2, NF-IL6, E-box, and CRE 24 (Fig. 4A ).
In accordance with our results, COX-2 gene expression was not relevant to NF-κB signaling; instead, ERK/p38 would dominate the downstream activation. Furthermore, published data has indicated a role for the ERK/p38 pathway in mediating CREB phosphorylation for regulation of cell function. 25, 26 To explore the attributes of CREB in COX-2 expression, a ChIP assay was used to analyze the binding interaction of CREB-1 and the COX-2 promoter in TSGH8301 cells. From the measurement results shown in Figure 4B , there was a slight enhancement observed regarding the binding amount of CREB-1 protein following 12 h of infection (MOI = 4). Subsequently, about a 1.3-fold increase was found through real-time PCR quantification in comparison with non-infected control samples (MOI = 0). Although the possibility that other transcription factors implicated in C. albicans-induced COX-2 gene transcription cannot be ruled out, these findings still provided evidence that CREB-1 played a partial role in COX-2 gene expression in TSGH8301 cells. 
Candida albicans-induced COX-2 expression is mediated by the EGF receptor
There has been significant evidence to demonstrate endocystic uptake of C. albicans by host immune or oral epithelial cells through pattern recognition receptors (PRRs), including Toll-like receptors (TLRs)-2 or -4, C-type lectin receptors (Dectin-2, Galectin-3, Mannose receptor and DC-SIGN), 27 and the recently found EGFR. 28 However, the mechanism regarding the surface interaction route driven by urinary bladder cells has remained obscure. We therefore turned to evaluate the involvement of receptors in the interaction of TSGH8301 cells with C. albicans using corresponding inhibitors to suppress each related signaling pathway. As depicted in Figure 5 , both the downstream p38 and ERK as well as COX-2 expression induced by Candida infection were almost completely abrogated by pretreatment with an EGFR inhibitor (PD168393), while these molecules obviously were not repressed under respective inactivation of surface TLR and Dectin signaling by the Myd88 inhibitor (ST2825) and Syk inhibitor, underlining the importance of EGFR in the interaction of TSGH8301 cells with C. albicans. These results suggested that the induced COX-2 expression during C. albicans invasion of urothelia would signal through EGFR instead of other conventional PRRs.
Discussion
In the current study we have explored a clear view of the host urothelium-C. albicans interaction in vitro that leads to subsequent inflammatory COX-2 expression, as summarized in Figure 6 . This pathway includes EGFR phosphorylation followed by ERK/p38 and RSK activation, which then stimulates COX-2 upregulation via enhanced CREB-1 transcription ability. Our results not only provide information about the mechanism underlying the C. albicansinduced urinary tract COX-2/PGE 2 expression but also help to develop therapeutic strategies in the future for urinary bladder infection by C. albicans. This study is the first to prove the activation of EGFR of urinary bladder cells during C. albicans infection. According to our data, it was manifested clearly that EGFR would dominate the COX-2 induction by C. albicans since the downstream effectors, such as ERK/p38 and RSK, as well as COX-2 expression were all inhibited after application of the EGFR inhibitor (Fig. 5) . In contrast to EGFR, TLRs and Dectins did not play significant roles in C. albicansinduced COX-2 expression. Why EGFR functions to mediate the COX-2 induction instead of conventional TLRs and Dectins is likely associated with the lower expression of TLRs and Dectins in urothelial tissues. In one study of oropharyngeal candidiasis, the authors concluded that EGFR and HER2 receptor work cooperatively to induce endocytosis of C. albicans hyphae in human oral epithelial cells. 28 In that report, two invasins Als3 and Ssa1 were found to induce the phosphorylation of EGFR and HER2 receptor. In our study, C. albicans also induced EGFR phosphorylation in human urothelial cells. Whether C. albicans 33 also affect the phosphorylation of CREB. Among these reports, it was also indicated that p38 and ERK were generally involved in contributing to CREB activation in the post-receptor signaling pathways. Given that CREB is a key factor for regulating gene transcription stimulated by associated upstream kinases, in this study we focused on CREB to examine C. albicans-induced COX-2 gene expression. Based on the ChIP assay results, we indeed found a slightly increased level (1.3-fold) of CREB-1 binding onto the COX-2 promoter (Fig. 4) , indicating CREB-1 was involved in COX-2 mRNA induction, but the fold change was lower than that in COX-2 protein induction (about twofold). There are three causes likely to explain this effect pertaining to the transcription manner of CREB: The first one is that CREB may act as the most dominant factor regulating COX-2 transcription, so that increased phosphorylated CREB exhibits higher transcriptional activity to drive COX-2 gene expression as opposed to simply relying on the DNA binding amount of CREB protein. Another concerning factor may be the transient expression state of CREB. When under the influence of external stress, one report indicated a role for sequential regulation in CREB through rapid processes including hyper-phosphorylation, ubiquitination, and subsequent proteasomal degradation. 34 Recently, one analysis using RNA-seq to identify signaling pathways governing the host response to C. albicans infection showed the time course of CREB induction, which reached its peak value soon after 1.5 h but declined to a lower level after the 8-h time point. 35 In this respect, it can be postulated reasonably that CREB protein amount has subsided gradually when observed at 12 h in our case. The other possibility that cannot be excluded is derived from the evidence considering other transcription factors, such as C/EBP, may still be implicated. 33, 36 It is worthwhile to deeply look into this subject in future investigations. Candida albicans is a major fungal and important opportunistic pathogen in humans. During infection, arachidonic acid is released from host cell membrane phospholipids, resulting in the generation of host-and yeast-derived lipid mediator PGE 2 , which could enhance the yeast-to-hypha transition in C. albicans and interfere with the host's immune responses. 19 Because PGE 2 has been reported to play a crucial role in germ-tube formation during C. albicans infection, 37 a vicious cycle seems to be built up to drive the inflammatory condition to worsen. Furthermore, it may make the host tissue suffer from chronic hyperplastic candidiasis that is capable of facilitating cancer formation via various kinds of mechanisms. 38 In summary, we demonstrated that COX-2 mRNA and protein were induced by C. albicans infection in TSGH8301 cells in time-and dose-dependent manners. Consequently, a significant amount of PGE 2 was produced ( Fig. 2) to conduct the subsequent inflammatory progression and promote the yeast-to-hypha transition that might induce cell death as reflected by the result of LDH release assays (Fig. 1B) . Therefore, inhibition of C. albicansinduced COX-2 expression might support the amelioration of clinical symptoms.
